| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Programmed cell death 1 ligand 1 |
|---|
| Ligand | BDBM363212 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Homogenous Time-Resolved Fluorescence (HTRF) Binding Assay |
|---|
| IC50 | 5.3±n/a nM |
|---|
| Citation |  Chupak, LS; Ding, M; Martin, SW; Zheng, X; Hewawasam, P; Connolly, TP; Xu, N; Yeung, K; Zhu, J; Langley, DR; Scola, PM Compounds useful as immunomodulators US Patent US9850225 Publication Date 12/26/2017 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Programmed cell death 1 ligand 1 |
|---|
| Name: | Programmed cell death 1 ligand 1 |
|---|
| Synonyms: | B7 homolog 1 | B7-H1 | B7H1 | B7H1 | CD274 | CD_antigen=CD274 | PD-L1 | PD1L1_HUMAN | PDCD1 ligand 1 | PDCD1L1 | PDCD1LG1 | PDL1 | Programmed cell death 1 ligand 1 | Programmed death ligand 1 |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 33278.49 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_109807 |
|---|
| Residue: | 290 |
|---|
| Sequence: | MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEME
DKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGG
ADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTT
TTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTH
LVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET
|
|
|
|---|
| BDBM363212 |
|---|
| n/a |
|---|
| Name | BDBM363212 |
|---|
| Synonyms: | (2R,3S)-2-((2-((3-cyanobenzyl)oxy)-6-methoxy-4-((2-methyl-[1,1′-biphenyl]-3-yl)methoxy)benzyl)amino)-3-hydroxybutanoic acid | US9850225, Example 1135 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C34H34N2O6 |
|---|
| Mol. Mass. | 566.6436 |
|---|
| SMILES | COc1cc(OCc2cccc(c2C)-c2ccccc2)cc(OCc2cccc(c2)C#N)c1CN[C@H]([C@H](C)O)C(O)=O |r| |
|---|
| Structure | 
|
|---|
Search and Browse
